Targeted Protein Degradation-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of Targeted Protein Degradation

• 1.1 Definition of Targeted Protein Degradation in This Report
• 1.2 Commercial Types of Targeted Protein Degradation
  • 1.2.1 Oral
  • 1.2.2 Intravenous
  • 1.2.3 Others
• 1.3 Downstream Application of Targeted Protein Degradation
  • 1.3.1 Hospital
  • 1.3.2 Research Institute
• 1.4 Development History of Targeted Protein Degradation
• 1.5 Market Status and Trend of Targeted Protein Degradation 2016-2026
  • 1.5.1 Global Targeted Protein Degradation Market Status and Trend 2016-2026
  • 1.5.2 Regional Targeted Protein Degradation Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Targeted Protein Degradation 2016-2021
• 2.2 Production Market of Targeted Protein Degradation by Regions
  • 2.2.1 Production Volume of Targeted Protein Degradation by Regions
  • 2.2.2 Production Value of Targeted Protein Degradation by Regions
• 2.3 Demand Market of Targeted Protein Degradation by Regions
• 2.4 Production and Demand Status of Targeted Protein Degradation by Regions
  • 2.4.1 Production and Demand Status of Targeted Protein Degradation by Regions 2016-2021
  • 2.4.2 Import and Export Status of Targeted Protein Degradation by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Targeted Protein Degradation by Types
• 3.2 Production Value of Targeted Protein Degradation by Types
• 3.3 Market Forecast of Targeted Protein Degradation by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Targeted Protein Degradation by Downstream Industry
• 4.2 Market Forecast of Targeted Protein Degradation by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Targeted Protein Degradation

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Targeted Protein Degradation Downstream Industry Situation and Trend Overview

Chapter 6 Targeted Protein Degradation Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Targeted Protein Degradation by Major Manufacturers
• 6.2 Production Value of Targeted Protein Degradation by Major Manufacturers
• 6.3 Basic Information of Targeted Protein Degradation by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Targeted Protein Degradation Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Targeted Protein Degradation Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Targeted Protein Degradation Major Manufacturers Introduction and Market Data

• 7.1 5AM Venture Management LLC
  • 7.1.1 Company profile
  • 7.1.2 Representative Targeted Protein Degradation Product
  • 7.1.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of 5AM Venture Management LLC
• 7.2 AbbVie Inc
  • 7.2.1 Company profile
  • 7.2.2 Representative Targeted Protein Degradation Product
  • 7.2.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of AbbVie Inc
• 7.3 Almac Group
  • 7.3.1 Company profile
  • 7.3.2 Representative Targeted Protein Degradation Product
  • 7.3.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Almac Group
• 7.4 Amgen Inc.
  • 7.4.1 Company profile
  • 7.4.2 Representative Targeted Protein Degradation Product
  • 7.4.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Amgen Inc.
• 7.5 Bayer AG
  • 7.5.1 Company profile
  • 7.5.2 Representative Targeted Protein Degradation Product
  • 7.5.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Bayer AG
• 7.6 Biogen Inc.
  • 7.6.1 Company profile
  • 7.6.2 Representative Targeted Protein Degradation Product
  • 7.6.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Biogen Inc.
• 7.7 C4 Therapeutics
  • 7.7.1 Company profile
  • 7.7.2 Representative Targeted Protein Degradation Product
  • 7.7.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of C4 Therapeutics
• 7.8 Cosmo Bio USA
  • 7.8.1 Company profile
  • 7.8.2 Representative Targeted Protein Degradation Product
  • 7.8.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Cosmo Bio USA
• 7.9 Covance Inc
  • 7.9.1 Company profile
  • 7.9.2 Representative Targeted Protein Degradation Product
  • 7.9.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Covance Inc
• 7.10 Eli Lilly and Company
  • 7.10.1 Company profile
  • 7.10.2 Representative Targeted Protein Degradation Product
  • 7.10.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
• 7.11 Gilead Sciences, Inc
  • 7.11.1 Company profile
  • 7.11.2 Representative Targeted Protein Degradation Product
  • 7.11.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Gilead Sciences, Inc
• 7.12 GlaxoSmithKline plc
  • 7.12.1 Company profile
  • 7.12.2 Representative Targeted Protein Degradation Product
  • 7.12.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc
• 7.13 Merck KGaA
  • 7.13.1 Company profile
  • 7.13.2 Representative Targeted Protein Degradation Product
  • 7.13.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Merck KGaA
• 7.14 Mission Therapeutics
  • 7.14.1 Company profile
  • 7.14.2 Representative Targeted Protein Degradation Product
  • 7.14.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Mission Therapeutics
• 7.15 Novartis AG
  • 7.15.1 Company profile
  • 7.15.2 Representative Targeted Protein Degradation Product
  • 7.15.3 Targeted Protein Degradation Sales, Revenue, Price and Gross Margin of Novartis AG
• 7.16 Pfizer Inc
• 7.17 Promega

Chapter 8 Upstream and Downstream Market Analysis of Targeted Protein Degradation

• 8.1 Industry Chain of Targeted Protein Degradation
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Targeted Protein Degradation

• 9.1 Cost Structure Analysis of Targeted Protein Degradation
• 9.2 Raw Materials Cost Analysis of Targeted Protein Degradation
• 9.3 Labor Cost Analysis of Targeted Protein Degradation
• 9.4 Manufacturing Expenses Analysis of Targeted Protein Degradation

Chapter 10 Marketing Status Analysis of Targeted Protein Degradation

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources